- Bupropion-Induced Dystonia in a Patient with Parkinson’s Disease
-
Monalisa Vegda, Samhita Panda
-
J Mov Disord. 2020;13(3):241-243. Published online August 31, 2020
-
DOI: https://doi.org/10.14802/jmd.20046
-
-
7,788
View
-
91
Download
-
2
Citations
-
 PDF Supplementary Material
-
Citations
Citations to this article as recorded by  - Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
Matteo Vismara, Beatrice Benatti, Gregorio Nicolini, Ilaria Cova, Edoardo Monfrini, Alessio Di Fonzo, Vincenza Fetoni, Caterina A. Viganò, Alberto Priori, Bernardo Dell’Osso
BMC Neurology.2022;[Epub] CrossRef - Experimental Dopamine Reuptake Inhibitors in Parkinson’s Disease: A Review of the Evidence
Thomas Müller
Journal of Experimental Pharmacology.2021; Volume 13: 397. CrossRef
|
KMDS
E-submission
